Evidence map›Paper›PMID 34932557›Full record

ArticlePLoS biology2021

Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.

Vanessa Herder, Kieran Dee, Joanna K Wojtus, Ilaria Epifano, Daniel Goldfarb, Christoforos Rozario, Quan Gu, Ana Da Silva Filipe, Kyriaki Nomikou, Jenna Nichols and 12 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Will COVID-19 become mild, like a cold?Epidemiology and infection · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. COVID-19 and Cancer Diseases-The Potential ofInternational journal of molecular sciences · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Vanessa HerderMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0003-4814-1382
Kieran DeeMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-3280-6768
Joanna K WojtusMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0003-4345-3475
Ilaria EpifanoMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-2056-0510
Daniel GoldfarbMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0001-6014-387X
Christoforos RozarioMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0003-2438-5219
Quan GuMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-1201-6734
Ana Da Silva FilipeMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-9442-2903
Kyriaki NomikouMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.
Jenna NicholsMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0003-0093-7170
Ruth F JarrettMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.
Andrew StevensonMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-5325-5360
Steven McFarlaneMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.
Meredith E StewartMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0001-6275-2740
Agnieszka M SzemielMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0003-3085-9994
Rute M PintoMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0003-3291-1397
Andreu Masdefiol GarrigaMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-2094-3001
Chris DavisMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-7317-3266
Jay AllanMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-6482-7125
Sheila V GrahamMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-7140-8279
Pablo R MurciaMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-4352-394X
Chris BoutellMRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland United Kingdom.ORCID 0000-0002-2970-7785
MRC University of Glasgow Centre for Virus Research · GB

Funding

Medical Research Council MC_PC_19026Medical Research Council MC_ST_U18018Medical Research Council MC_UU_12014/10Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_12014/5Medical Research Council MC_UU_12014/9Medical Research Council MC_UU_12018/12Medical Research Council MR/R502327/1
6 · The paper itself

Abstract

The pandemic spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of Coronavirus Disease 2019 (COVID-19), represents an ongoing international health crisis. A key symptom of SARS-CoV-2 infection is the onset of fever, with a hyperthermic temperature range of 38 to 41°C. Fever is an evolutionarily conserved host response to microbial infection that can influence the outcome of viral pathogenicity and regulation of host innate and adaptive immune responses. However, it remains to be determined what effect elevated temperature has on SARS-CoV-2 replication. Utilizing a three-dimensional (3D) air-liquid interface (ALI) model that closely mimics the natural tissue physiology of SARS-CoV-2 infection in the respiratory airway, we identify tissue temperature to play an important role in the regulation of SARS-CoV-2 infection. Respiratory tissue incubated at 40°C remained permissive to SARS-CoV-2 entry but refractory to viral transcription, leading to significantly reduced levels of viral RNA replication and apical shedding of infectious virus. We identify tissue temperature to play an important role in the differential regulation of epithelial host responses to SARS-CoV-2 infection that impact upon multiple pathways, including intracellular immune regulation, without disruption to general transcription or epithelium integrity. We present the first evidence that febrile temperatures associated with COVID-19 inhibit SARS-CoV-2 replication in respiratory epithelia. Our data identify an important role for tissue temperature in the epithelial restriction of SARS-CoV-2 independently of canonical interferon (IFN)-mediated antiviral immune defenses.

Indexed as

Hot TemperatureAdolescentAnimalsChlorocebus aethiopsCOVID-19Epithelial CellsFemaleGene Expression ProfilingHost-Pathogen InteractionsHumansImmunity, InnateInterferonsMaleMiddle AgedModels, BiologicalRespiratory MucosaInterferons

Identifiers

PMID34932557
PMCPMC8765667
OpenAlexW4200259943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.